Aim immunotech to report full year 2022 financial results on march 31, 2023 and host inaugural quarterly conference call and webcast

Ocala, fla., march 27, 2023 (globe newswire) -- aim immunotech inc. (nyse american: aim) (“aim” or the “company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases — including covid-19, the disease caused by the sars-cov-2 virus — today announced that it will report its financial results for the full year december 31, 2022 after market close on friday, march 31, 2023. aim immunotech management will host its inaugural quarterly conference call and live audio webcast to discuss the operational and financial results on monday, april 3rd at 8:30 am et.
AIM Ratings Summary
AIM Quant Ranking